Mitchell P. Kopin 13D and 13G filings for Phio Pharmaceuticals Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 90,204 5.600% | 82,687 (+1100.00%) | Filing |
| 2022-02-11 07:46 am Purchase | 2021-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 7,517 5.700% | 3,393 (+82.28%) | Filing |
| 2021-01-29 06:18 am Purchase | 2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 4,124 7.200% | 2,380 (+136.51%) | Filing |